Hematologic toxicity in BRCA1 and BRCA2 mutation carriers during chemotherapy: A retrospective matched cohort study

Women who inherit a BRCA1 or BRCA2 mutation have an increased risk of breast cancer. Preliminary evidence suggests they may also have defects in bone marrow function. To test this hypothesis, we conducted a multicenter, retrospective, matched cohort study, comparing women with localized breast cance...

Descripción completa

Detalles Bibliográficos
Autores principales: West, Allison H., Knollman, Hayley, Dugan, James, Hedeker, Donald, Handorf, Elisabeth A., Nielsen, Sarah M., Bealin, Lisa C., Goldblatt, Lindsay G., Willems, Heather, Daly, Mary B., Afghahi, Anosheh, Olopade, Olufunmilayo I., Hulick, Peter J., Shagisultanova, Elena, Huo, Dezheng, Obeid, Elias, Churpek, Jane E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745828/
https://www.ncbi.nlm.nih.gov/pubmed/31407530
http://dx.doi.org/10.1002/cam4.2471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745828/
https://www.ncbi.nlm.nih.gov/pubmed/31407530
http://dx.doi.org/10.1002/cam4.2471

Ejemplares similares